Alnylam Announces Second Annual Advocacy for Impact Grants Program

Go back to Alnylam Announces Second Annual Advocacy for Impact Grants Program
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 267.40 --0 (-0%)
Previous Close $267.40    52 Week High $109.10 
Open $267.40    52 Week Low $31.38 
Day High $267.40    P/E N/A 
Day Low $267.40    EPS $-1.45 
Volume 607